We are live on ! Find out more
CUTR

Cutera, Inc.

Delisted

CUTR was delisted on the 12th of March, 2025.

100 hedge funds and large institutions have $63.6M invested in Cutera, Inc. in 2023 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 38 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less call options, than puts

Call options by funds: $1.74M | Put options by funds: $2M

17% less funds holding

Funds holding: 120100 (-20)

29% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 38

53% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 38

54% less capital invested

Capital invested by funds: $137M → $63.6M (-$73.5M)

Holders
100
Holders Change
-20
Holders Change %
-16.67%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
18
Increased
27
Reduced
38
Closed
38
Calls
$1.74M
Puts
$2M
Net Calls
-$258K
Net Calls Change
+$2.88M

CUTR Hedge Fund Activity: Q4 2023 in Review

100 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Cutera, Inc. (CUTR) for Q4 2023, worth a combined $63.6M — down 54% from $137M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of CUTR and 18 opened new positions — a net loss of 20 holders — while 38 trimmed existing stakes and 27 added.

The largest buyer was Morgan Stanley, adding an estimated $3.25M. The largest seller was OrbiMed, exiting entirely with an estimated $3.63M sold.

  • 100 institutional investors held Cutera, Inc. (CUTR) as of Q4 2023, down from 120 in Q3 2023.
  • Funds reported $63.6M of Cutera, Inc. stock for Q4 2023, down 54% quarter-over-quarter.
  • 18 funds opened new Cutera, Inc. positions in Q4 2023 and 38 closed out, a net change of -20 holders.
  • The largest Cutera, Inc. buyer in Q4 2023 was Morgan Stanley, an estimated $3.25M added.
  • The largest Cutera, Inc. seller in Q4 2023 was OrbiMed, an estimated $3.63M sold.

Based on aggregated 13F filings for Q4 2023.